Integra Lifesciences Holdings (IART) Free Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.78% |
| Dec 31, 2025 | -15.72% |
| Sep 30, 2025 | -16.36% |
| Jun 30, 2025 | -19.47% |
| Mar 31, 2025 | -62.57% |
| Dec 31, 2024 | -20.60% |
| Sep 30, 2024 | -16.45% |
| Jun 30, 2024 | -19.10% |
| Mar 31, 2024 | -53.51% |
| Dec 31, 2023 | 15.01% |
| Sep 30, 2023 | -26.21% |
| Jun 30, 2023 | -4.72% |
| Mar 31, 2023 | -13.79% |
| Dec 31, 2022 | 103.61% |
| Sep 30, 2022 | 9.58% |
| Jun 30, 2022 | 28.88% |
| Mar 31, 2022 | 12.20% |
| Dec 31, 2021 | 37.16% |
| Sep 30, 2021 | 13.66% |
| Jun 30, 2021 | 23.21% |
| Mar 31, 2021 | 34.58% |
| Dec 31, 2020 | 41.78% |
| Sep 30, 2020 | 34.58% |
| Jun 30, 2020 | -3.26% |
| Mar 31, 2020 | -30.40% |
| Dec 31, 2019 | 63.21% |
| Sep 30, 2019 | 15.48% |
| Jun 30, 2019 | 34.46% |
| Mar 31, 2019 | 178.45% |
| Dec 31, 2018 | 19.80% |
| Sep 30, 2018 | 28.94% |
| Jun 30, 2018 | 28.58% |
| Mar 31, 2018 | 60.63% |
| Dec 31, 2017 | 40.19% |
| Sep 30, 2017 | 35.52% |
| Jun 30, 2017 | 27.30% |
| Mar 31, 2017 | -2.11% |
| Dec 31, 2016 | -21.77% |
| Sep 30, 2016 | 28.06% |
| Jun 30, 2016 | 11.41% |
| Mar 31, 2016 | -1.61% |
| Dec 31, 2015 | 4.24% |
| Sep 30, 2015 | -8.68% |
| Jun 30, 2015 | 77.75% |
| Mar 31, 2015 | -5.06% |
| Dec 31, 2014 | -17.03% |
| Sep 30, 2014 | 1.68% |